Why the study?
What is the pattern of atrial natriuretic peptide (ANP) release during and after induced ventricular tachycardia in humans?
What is the pattern of atrial natriuretic peptide (ANP) release during and after induced ventricular tachycardia in humans?
The study demonstrates a temporal delay between changes in atrial pressure and ANP secretion during ventricular tachycardia, supporting a central role for atrial pressure in determining ANP release.
Answers are grounded in this paper and cite their sources.
Single-case observation of delayed ANP release during tachycardia should not change practice; leaves open confirmation of atrial pressure dependence.
Plasma levels of atrial natriuretic peptide (ANP) are high in many patients with tachycardia, but patterns of release with onset and termination of tachycardia and relationships to haemodynamic recordings are not clear. Blood for ANP measurements was therefore drawn from the coronary sinus, femoral artery and femoral vein, and simultaneous haemodynamic recordings were made in five patients before, during and after induction of stable ventricular tachycardia for 30 min. 2. Tachycardia induced increases in ANP to peak levels, 2.6 to 5.7 times higher than baseline values at 20 min or later, whereas maximum haemodynamic changes, including a rise in pulmonary artery diastolic pressure, were achieved within 4 min. 3. Reversion to sinus rhythm resulted in immediate changes in haemodynamic recordings, whereas ANP levels in arterial and venous plasma fell sluggishly with an apparent half-life of 9.6 and 7 min, respectively. 4. The results support a central role for atrial pressure in determining ANP secretion, but demonstrate a temporal delay between changes in atrial pressure and ANP secretion.
No takes yet. Share an insight, caveat, or question.
Crozier et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: